Essex Bio-Technology Statistics

Total Valuation

HKG:1061 has a market cap or net worth of HKD 2.49 billion. The enterprise value is 2.12 billion.

Market Cap	2.49B
Enterprise Value	2.12B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	May 23, 2025

Share Statistics

HKG:1061 has 567.01 million shares outstanding. The number of shares has decreased by -2.24% in one year.

Current Share Class	n/a
Shares Outstanding	567.01M
Shares Change (YoY)	-2.24%
Shares Change (QoQ)	-3.59%
Owned by Insiders (%)	54.08%
Owned by Institutions (%)	2.81%
Float	260.38M

Valuation Ratios

The trailing PE ratio is 8.27 and the forward PE ratio is 7.72.

PE Ratio	8.27
Forward PE	7.72
PS Ratio	1.49
PB Ratio	1.17
P/TBV Ratio	2.11
P/FCF Ratio	7.70
P/OCF Ratio	6.77
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.27, with an EV/FCF ratio of 6.55.

EV / Earnings	6.90
EV / Sales	1.27
EV / EBITDA	5.27
EV / EBIT	6.03
EV / FCF	6.55

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.09.

Current Ratio	1.81
Quick Ratio	1.62
Debt / Equity	0.09
Debt / EBITDA	0.46
Debt / FCF	0.58
Interest Coverage	58.28

Financial Efficiency

Return on equity (ROE) is 15.18% and return on invested capital (ROIC) is 9.79%.

Return on Equity (ROE)	15.18%
Return on Assets (ROA)	7.63%
Return on Invested Capital (ROIC)	9.79%
Return on Capital Employed (ROCE)	15.60%
Revenue Per Employee	1.15M
Profits Per Employee	211,877
Employee Count	1,450
Asset Turnover	0.57
Inventory Turnover	2.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +100.91% in the last 52 weeks. The beta is -0.11, so HKG:1061's price volatility has been lower than the market average.

Beta (5Y)	-0.11
52-Week Price Change	+100.91%
50-Day Moving Average	3.42
200-Day Moving Average	2.82
Relative Strength Index (RSI)	60.48
Average Volume (20 Days)	3,182,160

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1061 had revenue of HKD 1.67 billion and earned 307.22 million in profits. Earnings per share was 0.53.

Revenue	1.67B
Gross Profit	1.50B
Operating Income	354.79M
Pretax Income	375.50M
Net Income	307.22M
EBITDA	400.71M
EBIT	354.79M
Earnings Per Share (EPS)	0.53

Full Income Statement

Balance Sheet

The company has 560.74 million in cash and 187.04 million in debt, giving a net cash position of 373.70 million or 0.66 per share.

Cash & Cash Equivalents	560.74M
Total Debt	187.04M
Net Cash	373.70M
Net Cash Per Share	0.66
Equity (Book Value)	2.12B
Book Value Per Share	3.74
Working Capital	574.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 368.47 million and capital expenditures -44.40 million, giving a free cash flow of 324.07 million.

Operating Cash Flow	368.47M
Capital Expenditures	-44.40M
Free Cash Flow	324.07M
FCF Per Share	0.57

Full Cash Flow Statement

Margins

Gross margin is 89.75%, with operating and profit margins of 21.25% and 18.40%.

Gross Margin	89.75%
Operating Margin	21.25%
Pretax Margin	22.49%
Profit Margin	18.40%
EBITDA Margin	24.00%
EBIT Margin	21.25%
FCF Margin	19.41%

Dividends & Yields

This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 2.74%.

Dividend Per Share	0.12
Dividend Yield	2.74%
Dividend Growth (YoY)	166.67%
Years of Dividend Growth	1
Payout Ratio	19.39%
Buyback Yield	2.24%
Shareholder Yield	4.98%
Earnings Yield	12.31%
FCF Yield	12.99%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1061 has an Altman Z-Score of 3.2.

Altman Z-Score	3.2
Piotroski F-Score	n/a